HLA-C and neoplasm: Anti-tumor CD8+ T cell activity is induced by DCs, which acquire, process, and present tumor-associated antigens (TAAs) on MHC molecules (signal 1) and provide co-stimulation (signal 2) and soluble factors (signal 3) to shape the T cell responses [8,9].